Nodular lymphocyte predominant Hodgkin lymphoma

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:86893C81.0
Who is this for?
Show terms as
2Active trials32Specialists8Treatment centers

Where are you in your journey?

ℹ
UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Also known as:

NLPHL

Clinical phenotype terms— hover any for plain English:

Breast carcinomaHP:0003002Abnormal bone marrow cell morphologyHP:0005561B-cell lymphomaHP:0012191
Orphanet ↗NORD ↗

FDA & Trial Timeline

3 events
Apr 2024Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)

St. Jude Children's Research Hospital

TrialRECRUITING
Jan 2024Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial

National Cancer Institute (NCI) — PHASE2

TrialRECRUITING
Jan 2006Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin Disease

Children's Oncology Group — PHASE2

TrialACTIVE NOT RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Nodular lymphocyte predominant Hodgkin lymphoma.

2 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

2 recruitingView all trials with filters →
Phase 21 trial
Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial
Phase 2
Actively Recruiting
PI: Raphael E Steiner (University of Texas MD Anderson Cancer Center LAO) · Sites: Duarte, California; Aventura, Florida +33 more · Age: 18–99 yrs
View on ClinicalTrials.gov ↗I'm interested →
Other1 trial
Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
Actively Recruiting
PI: Valerie Crabtree, PhD (St. Jude Children's Research Hospital) · Sites: Aurora, Colorado; Boston, Massachusetts +3 more · Age: 8–99 yrs
View on ClinicalTrials.gov ↗I'm interested →

Specialists

Showing 25 of 32View all specialists →
DM
Dieter Koerholz, MD
Specialist
PI on 3 active trials
FM
Frank G. Keller, MD
Specialist
PI on 1 active trial
RM
Ranjana H Advani, MD
STANFORD, CA
Specialist
PI on 2 active trials
AH
Alex F Herrera
Specialist
PI on 7 active trials
AM
Andreas Engert, MD
Specialist
PI on 1 active trial
RM
Richard T Hoppe, MD
LUTHERVILLE TIMONIUM, MD
Specialist
PI on 1 active trial
KM
Kristie Blum, MD
ATLANTA, GA
Specialist
PI on 4 active trials
AM
Ajay Major, MD, MBA
AURORA, CO
Specialist
PI on 1 active trial
RS
Raphael E Steiner
NEW YORK, NY
Specialist
PI on 2 active trials
AP
Andreas Engert, Prof.
Specialist
PI on 5 active trials
RN
Ryotaro Nakamura
Duarte, California
Specialist

Rare Disease Specialist

PI on 6 active trials
JM
Jamie Flerlage, MD, MS
ROCHESTER, NY
Specialist
PI on 1 active trial
MK
Mark Kirschbaum
HERSHEY, PA
Specialist
PI on 4 active trials2 Nodular lymphocyte predominant Hodgkin lymphoma publications
DF
Debra Friedman
Specialist
PI on 1 active trial
PM
Peter Johnson, MD
Specialist
PI on 2 active trials
AP
Anna Jones, PhD
Specialist
PI on 1 active trial
KB
Kristie Blum
ATLANTA, GA
Specialist
PI on 5 active trials
LM
Leo Gordon, MD
Specialist
PI on 3 active trials1 Nodular lymphocyte predominant Hodgkin lymphoma publication
TH
Terzah Horton
HOUSTON, TX
Specialist
PI on 2 active trials
TM
Tanya Trippett, MD
NEW YORK, NY
Specialist
PI on 7 active trials
VP
Valerie Crabtree, PhD
STARKVILLE, MS
Specialist
PI on 2 active trials
MM
Matthew Rees, MD
ROCHESTER, MN
Specialist
PI on 1 active trial
PM
Patrick A. Thompson, MD
Specialist
PI on 2 active trials
BM
Beth Christian, MD
Specialist
PI on 2 active trials
BA
Burton E Appel
Birmingham, Alabama
Specialist

Rare Disease Specialist

PI on 1 active trial5 Nodular lymphocyte predominant Hodgkin lymphoma publications

Treatment Centers

8 centers
⚗️ Trial Site

Children's Hospital Colorado

📍 Aurora, Colorado

👤 Zachary Grinspan, MD

⚗️ Trial Site

Arkansas Children's Hospital

📍 Little Rock, Arkansas

⚗️ Trial Site

Children's Hospital of Orange County

📍 Orange, California

👤 Richard Neibeger, MD

⚗️ Trial Site

University of Alabama at Birmingham Cancer Center

📍 Birmingham, Alabama

⚗️ Trial Site

Banner University Medical Center - Tucson

📍 Tucson, Arizona

⚗️ Trial Site

University of Arkansas for Medical Sciences

📍 Little Rock, Arkansas

⚗️ Trial Site

UCSF Benioff Children's Hospital Oakland

📍 Oakland, California

👤 Neeta Thakur, MD, MPH

🔬 UDN

Harvard/MGH UDN Clinical Site ↗

Massachusetts General Hospital

📍 Boston, MA

Travel Grants

No travel grants are currently matched to Nodular lymphocyte predominant Hodgkin lymphoma.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Nodular lymphocyte predominant Hodgkin lymphomaForum →

No community posts yet. Be the first to share your experience with Nodular lymphocyte predominant Hodgkin lymphoma.

Start the conversation →

Latest news about Nodular lymphocyte predominant Hodgkin lymphoma

Disease timeline:

New recruiting trial: Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)

A new clinical trial is recruiting patients for Nodular lymphocyte predominant Hodgkin lymphoma

New recruiting trial: Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial

A new clinical trial is recruiting patients for Nodular lymphocyte predominant Hodgkin lymphoma

New trial: Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin Disease

Phase PHASE2 trial recruiting. Conventional Surgery

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Nodular lymphocyte predominant Hodgkin lymphoma

Are there clinical trials for Nodular lymphocyte predominant Hodgkin lymphoma?

Yes — 2 recruiting clinical trials are currently listed for Nodular lymphocyte predominant Hodgkin lymphoma on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Nodular lymphocyte predominant Hodgkin lymphoma?

25 specialists and care centers treating Nodular lymphocyte predominant Hodgkin lymphoma are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.